Cargando…

BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia

Detalles Bibliográficos
Autores principales: Chen, Cunte, Zhang, Yuping, Zeng, Xiangbo, Zeng, Chengwu, Przybylski, Grzegorz K, Li, Yangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697049/
http://dx.doi.org/10.1177/11795549231216427
_version_ 1785154700911312896
author Chen, Cunte
Zhang, Yuping
Zeng, Xiangbo
Zeng, Chengwu
Przybylski, Grzegorz K
Li, Yangqiu
author_facet Chen, Cunte
Zhang, Yuping
Zeng, Xiangbo
Zeng, Chengwu
Przybylski, Grzegorz K
Li, Yangqiu
author_sort Chen, Cunte
collection PubMed
description
format Online
Article
Text
id pubmed-10697049
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-106970492023-12-06 BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia Chen, Cunte Zhang, Yuping Zeng, Xiangbo Zeng, Chengwu Przybylski, Grzegorz K Li, Yangqiu Clin Med Insights Oncol Letter to the Editor SAGE Publications 2023-12-04 /pmc/articles/PMC10697049/ http://dx.doi.org/10.1177/11795549231216427 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Letter to the Editor
Chen, Cunte
Zhang, Yuping
Zeng, Xiangbo
Zeng, Chengwu
Przybylski, Grzegorz K
Li, Yangqiu
BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
title BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
title_full BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
title_fullStr BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
title_full_unstemmed BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
title_short BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia
title_sort bcl11b mutations are associated with higher cd8+ t-cell percentage and favorable clinical outcomes in patients with t-cell acute lymphoblastic leukemia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697049/
http://dx.doi.org/10.1177/11795549231216427
work_keys_str_mv AT chencunte bcl11bmutationsareassociatedwithhighercd8tcellpercentageandfavorableclinicaloutcomesinpatientswithtcellacutelymphoblasticleukemia
AT zhangyuping bcl11bmutationsareassociatedwithhighercd8tcellpercentageandfavorableclinicaloutcomesinpatientswithtcellacutelymphoblasticleukemia
AT zengxiangbo bcl11bmutationsareassociatedwithhighercd8tcellpercentageandfavorableclinicaloutcomesinpatientswithtcellacutelymphoblasticleukemia
AT zengchengwu bcl11bmutationsareassociatedwithhighercd8tcellpercentageandfavorableclinicaloutcomesinpatientswithtcellacutelymphoblasticleukemia
AT przybylskigrzegorzk bcl11bmutationsareassociatedwithhighercd8tcellpercentageandfavorableclinicaloutcomesinpatientswithtcellacutelymphoblasticleukemia
AT liyangqiu bcl11bmutationsareassociatedwithhighercd8tcellpercentageandfavorableclinicaloutcomesinpatientswithtcellacutelymphoblasticleukemia